Your browser doesn't support javascript.
loading
Discovery of a First-in-Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy.
Li, Yue; Liu, Yuanyuan; Zhang, Yong; Wu, Yong; Xing, Zili; Wang, JianFei; Fan, Guo-Huang.
Afiliación
  • Li Y; Department of Medicinal Chemistry, Immunophage Biotech Co., Ltd, No. 10 Lv Zhou Huan Road, Shanghai 201112, P. R. China.
  • Liu Y; Department of Neurosciences, Immunophage Biotech Co., Ltd, No. 10 Lv Zhou Huan Road, Shanghai 201112, P. R. China.
  • Zhang Y; Guangxi Key Laboratory of Regenerative Medicine, and Guangxi Key Laboratory of Brain Science, Department of Cell Biology and Genetics, School of Basic Medical Sciences, Guangxi Medical University, Nanning 530021, Guangxi , China.
  • Wu Y; Department of Integrated Biological Platform Sciences, Immunophage Biotech Co., Ltd, No. 10 Lv Zhou Huan Road, Shanghai 201112, P. R. China.
  • Xing Z; Department of Medicinal Chemistry, Immunophage Biotech Co., Ltd, No. 10 Lv Zhou Huan Road, Shanghai 201112, P. R. China.
  • Wang J; Department of Neurosciences, Immunophage Biotech Co., Ltd, No. 10 Lv Zhou Huan Road, Shanghai 201112, P. R. China.
  • Fan GH; Executive Office, Immunophage Biotech Co., Ltd, No. 10 Lv Zhou Huan Road, Shanghai 201112, P. R. China.
J Med Chem ; 66(18): 12762-12775, 2023 Sep 28.
Article en En | MEDLINE | ID: mdl-37696000
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2023 Tipo del documento: Article